COORDINATE-Diabetes

COORDINATE-Diabetes was a cluster-randomized, controlled trial to assess the impact of a multifaceted educational intervention for healthcare staff on prescription rates for 3 groups of evidence-based therapies used to treat type-II diabetes and cardiovascular disease.

Sites randomized to the intervention received site-specific training and mentoring, as well as access to a suite of tools and resources to support intervention activities. See our Resources page for access to these tools.

The study enrolled 1049 participants at 42 cardiology clinics across the U.S. Participants were followed through review of clinic EHR data and telephone interviews for 6 to 12 months, depending on enrollment date, to collect information regarding medications and health outcomes.

The study was designed and conducted by the Duke Clinical Research Institute (Durham, NC). Funding was provided by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Lilly USA, LLC.

Resources

COORDINATE-Diabetes tools and tips to support local implementation

Explore Resources

Publications

See what we’ve learned from the COORDINATE-Diabetes study

Explore Publications

Christopher Granger, MD
Principal Investigator
Read bio for Christopher Granger

Neha Pagidipati, MD, MPH
Co-Principal Investigator
Read bio for Neha Pagidipati

Renato Lopes, MD, PhD
Faculty Investigator
Read bio for Renato Lopes

Jennifer Green, MD
Faculty Investigator
Read bio for Jennifer Green

Adam Nelson, MD
Faculty Investigator
Read bio for Adam Nelson

Vanita R. Aroda, MD
Associate Professor of Medicine
Harvard Medical School (Boston, MA)

Matthew A. Cavender, MD, MPH
Associate Professor of Medicine
University of North Carolina (Chapel Hill, NC)

Tanya Szesny Gaynor, MPAS, PA-C
Director, Strategy & Operations, Cardiometabolism and Respiratory
Clinical Development & Medical Affairs
Boehringer Ingelheim Pharmaceuticals, Inc

Julienne Kirk, PharmD, CDE, BCPS
Professor, Family and Community Medicine
Wake Forest University School of Medicine (Winston-Salem, NC)

Ildiko Lingvay, MD, MPH, MSCS
Professor of Medicine, Department of Internal Medicine/Endocrinology
UT Southwestern Medical Center at Dallas
(Dallas, TX)

Melissa Magwire, RN, MSN, CDE
Program Director, Cardiometabolic Center Alliance
Saint Luke’s Mid America Heart Institute
(Kansas City, MO)